日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ufmylation-Deficient DDRGK1 Ameliorates Obesity by Inhibiting FASN-Mediated Adipocyte Lipogenesis

Ufmylation 缺陷的 DDRGK1 通过抑制 FASN 介导的脂肪细胞脂肪生成来改善肥胖。

Li, Yin; Zhou, Tangjun; Yang, Xiao; Rong, Kewei; Cao, Xiankun; Shi, Lei; Wang, Xin; Wan, Hongjin; Cui, Lei; Liu, Kexin; Xing, Tong; Zhang, Hang; Zhao, Chen; Guo, Tingxian; Ma, Peixiang; Zhao, Jie; Qin, An

Engineered Spirulina platensis for treating rheumatoid arthritis and restoring bone homeostasis.

工程化螺旋藻用于治疗类风湿性关节炎和恢复骨骼稳态

Yang Xiao, Rong Kewei, Fu Shaotian, Yang Yangzi, Liu Shasha, Zhang Chenyu, Xu Kang, Zhang Kai, Zhu Yingchun, Hao Yongqiang, Zhao Jie, Fu Jingke

Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non-small cell lung cancer

临床和动态循环细胞因子谱特征与晚期非小细胞肺癌患者接受免疫检查点抑制剂治疗后长期无进展生存期获益相关

Deng, Jia-Yi; Gao, Ming; Fan, Xue; Yan, Hong-Hong; Luo, Wei-Chi; Yang, Ming-Yi; Yang, Xiao-Rong; Chen, Zhi-Hong; Xu, Chong-Rui; Zhou, Qing

Partial response to lorlatinib in thoracic inflammatory myofibroblastic tumor harboring complex and rare ALK fusions: a case report

一例携带复杂罕见ALK融合基因的胸腔炎性肌纤维母细胞瘤患者对劳拉替尼治疗有部分反应:病例报告

Tang, Li-Bo; Peng, Ying-Long; Yang, Xiao-Rong; Li, Jia-Ting; Lu, Chang; Zheng, Mei-Mei; Sun, Lu; Yang, Zheng; Yan, Li-Xu; Deng, Yu; Chen, Zhi-Hong; Lv, Si-Di; Zhou, Qing; Xu, Chong-Rui

Potential therapeutic targets for bladder cancer: a proteome-wide Mendelian randomization study.

膀胱癌的潜在治疗靶点:一项基于蛋白质组的孟德尔随机化研究

Liu Jia-Hao, Du Yuan-Zhuo, Liu Fang, Yang Lin, Liu Xiao-Qiang, Fu Bin, Yang Xiao-Rong

A perivascular epithelioid cell neoplasm of the bladder diagnosed after six years: A case report

膀胱血管周围上皮样细胞肿瘤六年后的诊断:病例报告

Yang, Ji-Yao; Yang, Xiao-Rong; Hei, Wei-Xiang; Liu, Yi-Dao

Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer

肠道菌群分布特征及动态变化与EGFR突变型非小细胞肺癌免疫治疗疗效的相关性研究

Luo, Wei-Chi; Mei, Shi-Qi; Huang, Zi-Jian; Chen, Zhi-Hong; Zhang, Yi-Chen; Yang, Ming-Yi; Liu, Jia-Qi; Xu, Jing-Yan; Yang, Xiao-Rong; Zhong, Ri-Wei; Tang, Li-Bo; Yin, Lin-Xi; Deng, Yu; Peng, Ying-Long; Lu, Chang; Chen, Bao-Long; Ke, Dong-Xian; Tu, Hai-Yan; Yang, Jin-Ji; Xu, Chong-Rui; Wu, Yi-Long; Zhou, Qing

Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis

癌症患者再次使用免疫检查点抑制剂的安全性、有效性和生存结果:系统评价和荟萃分析

Liu, Shi-Jia; Yan, Lun-Jie; Wang, Han-Chao; Ding, Zi-Niu; Liu, Hui; Zhang, Xiao; Pan, Guo-Qiang; Han, Cheng-Long; Tian, Bao-Wen; Yang, Xiao-Rong; Tan, Si-Yu; Dong, Zhao-Ru; Wang, Dong-Xu; Yan, Yu-Chuan; Li, Tao

EGFR exon 20 insertion mutation and MET exon 14 skipping mutation in non-small cell lung cancer: a scoping review in the Chinese population

EGFR 20号外显子插入突变和MET 14号外显子跳跃突变在非小细胞肺癌中的研究:一项针对中国人群的范围综述

Yang, Xiao-Rong; Zhong, Si-Min; Jin, Zhen-Yi; Gào, Xīn; Wu, Ying; Zhou, Qing; Li, Yang-Qiu; Liu, Si-Yang Maggie; Wu, Yi-Long

Patterns of failure and the subsequent treatment after progression on first-line immunotherapy monotherapy in advanced non-small cell lung cancer: a retrospective study

晚期非小细胞肺癌一线免疫单药治疗后疾病进展的失败模式及后续治疗:一项回顾性研究

Deng, Jia-Yi; Yang, Ming-Yi; Yang, Xiao-Rong; Chen, Zhi-Hong; Xu, Chong-Rui; Zhou, Qing